Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 5, 2012, Pages

  Kim, Jun Won ^a   Kim, Yong Bae ^a   Choi, Jun Jeong ^a   Koom, Woong Sub ^a   Kim, Hoguen ^a   Kim, Nam Kyu ^a   Ahn, Joong Bae ^a   Lee, Ikjae ^a   Cho, Jae Ho ^a   Keum, Ki Chang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL; CHEMORADIATION; DISEASE-FREE SURVIVAL; DISTANT METASTASIS; FAILURE-FREE SURVIVAL; IMMUNOSTAINING; KINASE INHIBITORS; LEUCOVORIN; MOLECULAR MARKER; MULTI VARIATE ANALYSIS; OVER-EXPRESSION; OVERALL SURVIVAL RATES; PROGNOSTIC FACTORS; RECTAL ADENOCARCINOMA; RECTAL CANCER; STRONG CORRELATION; SURGICAL SPECIMENS; SYNTHASES; TNM STAGE; TREATMENT OUTCOMES;

CHEMOTHERAPY; DISEASES; FORECASTING; PATHOLOGY; SURGERY;

CHEMORADIOTHERAPY;

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LOCAL FAILURE FREE SURVIVAL; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CARCINOMA; RECTUM RESECTION; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RADIATION DOSAGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTAL NEOPLASMS; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84869098688     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.07.2371     Document Type: Article

References (22)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. A.J. Dannenberg, S.M. Lippman, and J.R. Mann Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention J Clin Oncol 23 2005 254 266
3. C.G. Willett, S.V. Kozin, and D.G. Duda Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice Semin Oncol 33 2006 S35 S40
4. F. Al-Mulla, S. Hagan, and A.I. Behbehani Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients J Clin Oncol 24 2006 5672 5679
5. F.L. Greene, D.L. Page, and I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer-Verlag New York pp. 99-106
6. NIH consensus conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1450
7. Y.B. Kim, G.E. Kim, and N.H. Cho Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy Cancer 95 2002 531 539
8. L.T. Soumaoro, H. Uetake, and T. Higuchi Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer Clin Cancer Res 10 2004 8465 8471
9. I.D. Nagtegaal, and P. Quirke What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26 2008 303 312
10. J.E. Tepper, M.J. O'Connell, and D. Niedzwiecki Impact of number of nodes retrieved on outcome in patients with rectal cancer J Clin Oncol 19 2001 157 163
11. W.L. Xie, J.G. Chipman, and D.L. Robertson Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc Natl Acad Sci U S A 88 1991 2692 2696
12. Y. Kakiuchi, S. Tsuji, and M. Tsujii Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis Cancer Res 62 2002 1567 1572
13. M. Stolina, S. Sharma, and Y. Lin Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J Immunol 164 2000 361 370
14. S. Cascinu, F. Graziano, and V. Catalano An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation Br J Cancer 86 2002 744 749
15. T. Tokunaga, Y. Oshika, and Y. Abe Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer Br J Cancer 77 1998 998 1002
16. Z. Fu, Y. Kitagawa, and R. Shen Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer Prostate 66 2006 248 256
17. F. Bertolini, C. Bengala, and L. Losi Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy Int J Radiat Oncol Biol Phys 68 2007 1455 1461
18. E. Fernebro, P. Bendahl, and M. Dictor Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations Int J Cancer 111 2004 921 928
19. J.P. Kuebler, H.S. Wieand, and M.J. O'Connell Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2007 2198 2204
20. J. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
21. I. Stelzmueller, M. Zitt, and F. Aigner Postoperative morbidity following chemoradiation for locally advanced low rectal cancer J Gastrointest Surg 13 2009 657 667
22. C.G. Willett, D.G. Duda, and E. di Tomaso Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study J Clin Oncol 27 2009 3020 3026